Dr. Schreiber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Colorado
Denver, CO 80202
Education & Training
University of ColoradoResidency, Internal Medicine, 2018 - 2021- University of Colorado School of Medicine Anschutz Medical CampusClass of 2018
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsOvercoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.Stephen G Smoots, Anna R Schreiber, Marilyn M Jackson, Stacey M Bagby, Adrian T A Dominguez
Breast Cancer Research. 2024-03-01 - 7 citationsEvaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare studyAnna R Schreiber, Jodi A. Kagihara, Megan Eguchi, Peter Kabos, Christine M. Fisher
Breast Cancer Research and Treatment. 2021-10-27 - 8 citationsTackling metastatic triple-negative breast cancer with sacituzumab govitecan.Anna R Schreiber, Michelle Andress, Jennifer R. Diamond
Expert Review of Anticancer Therapy. 2021-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
